CLINICAL_TRIALS trial_result · 2019-10-10

Clinical Trial Update: Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib

A completed clinical trial evaluating first-line sunitinib in metastatic renal cell carcinoma with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Pfizer | Conditions: Metastatic Renal Cell Carcinoma | Status: COMPLETED | Results posted: 2019-10-10